Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment
公司新闻稿,非独立证据:总部位于巴黎的 Rivercell 称已完成由 HV 领投(HCVC、Alven、Bpifrance Digital Venture 参投)的 2,500 万美元种子轮,用于扩大数据生成平台与巴黎湿实验室并启动 AI 虚拟细胞项目;称平台不限适应症。未报告任何模型结果或数据。
- 作者 / 机构
- Rivercell (company press release via Business Wire)
- 发表于
- Business Wire (company press release)
- 日期
- 2026-10-07
- 类型
- 新闻
- 年份
- 2026
- 原文
- https://www.businesswire.com/news/home/20261007283522/en/Rivercell-Launches-With-%2425-Million-to-Build-Data-Platforms-and-AI-Models-That-Predict-How-Human-Cells-Respond-to-Treatment
- 核验来源
- Business Wire release page opened 2026-10-19 (primary publisher of company release; claims are the company's own); same text mirrored by BioSpace/Yahoo; TNW and Sifted also report it
被 GlioState 专题引用
尚未被任何研究专题页引用。
涉及的实体
- AI 虚拟细胞 模型